Abstract
Background
Anti-glomerular basement membrane (anti-GBM) disease is thought to be distinct from vasculitis. In contrast, there have been several papers suggesting the presence of angiitis in cases that were positive for anti-GBM antibody (Ab), as well as for either myeloperoxidase (MPO)- or proteinase 3 (PR3)-anti-neutrophil cytoplasmic antibody (ANCA) (Group I). We experienced four patients who had anti-GBM Abs, but not MPO- and PR3-ANCA (Group II), and two of these patients were found to have vasculitis. Therefore, we performed an in-depth study on these two patients.
Methods
The patients with anti-GBM disease were isolated from 578 cases whose renal tissues were examined, and they were categorized into two groups. We have already published the data about Group I. We then proceeded to study two vasculitic patients in Group II clinically, pathologically, and serologically. The anti-GBM Ab and ANCA levels were detected by enzyme-linked immunosorbent assays. Renal specimens were studied by routine staining as well as immunohistochemical investigations of CD31 and type IV collagen.
Results
The total number of patients with anti-GBM disease was 7 (7/578 = 1.2%), with 3 patients belonging to Group I and 4 patients belonging to Group II. Two patients in Group II were diagnosed to have vasculitis, but the remaining 2 patients did not. One vasculitic patient was complicated by pulmonary hemorrhage, while the other vasculitic patient displayed peripheral neuropathy as well as a small cavity lesion in the lung. The latter patient was found to be positive for perinuclear (p)-ANCA, but not for any other ANCA subsets. The renal pathology in the two vasculitic patients showed crescentic glomerulonephritis (CSGN) and immunoglobulin (Ig) G linear deposits along the glomerular capillary loops. The former patient showed fibrinoid angiitis in an afferent arteriole as well as peritubular capillaritis. The latter patient demonstrated peritubular capillaritis. These peritubular capillaritides were diagnosed by the loss of CD31 and type IV collagen staining, the blurred appearance of peritubular capillary walls by periodic acid-Schiff staining, and the pericapillary infiltration of inflammatory cells.
Conclusion
The incidence of anti-GBM disease was very low, and our patients were categorized into two groups (Groups I and II) based on whether or not they were positive for MPO- or PR3-ANCA. Two patients in Group II were found to have vasculitis. According to our results, we concluded that the anti-GBM disease of Group II could also be associated with vasculitis.
Similar content being viewed by others
References
Goodpasture WE. The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci. 1919;158:863–70.
Stanton MC, Tange JD. Goodpasture’s syndrome: pulmonary hemorrhage associated with glomerulonephritis. Aust NZ J Med. 1958;7:132–44.
Wieslander J, Barr JF, Butowski RJ, Edwards SJ, Bygren P, Heinegard D, et al. Goodpasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagen. Proc Natl Acad Sci USA. 1984;81:3838–42.
Rees AJ, Lockwood CM. Antiglomerular basement membrane antibody-mediated nephritis. In: Schrier RW, Gottschalk CW, editors. Disease of the kidney. Boston: Little Brown; 1988. p. 2091–126.
O’Donoghue DJ, Short CD, Brenchley PE, Lawler W, Ballardie FW. Sequential development of systemic vasculitis with anti-neutrophil cytoplasmic antibodies complicating anti-glomerular basement membrane disease. Clin Nephrol. 1989;32:251–5.
Jayne DRW, Marshall PD, Jones SJ, Lockwood M. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int. 1990;37:965–70.
Bosch X, Mirapeix E, Font J, Borrellas X, Rodriguez R, Lopez-Soto A, et al. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement disease. Clin Nephrol. 1991;36:107–13.
Arimura Y, Minoshima S, Kamiya Y, Nakabayashi K, Kitamoto K, Nagasawa T. A case of Goodpasture’s syndrome associated with anti-myeloperoxidase antibodies. Intern Med. 1992;31:234–43.
Bonsib SM, Goelen JA, Kemp JD, Chandran P, Shadur C, Wilson L. Coexistent anti-neutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody associated disease: report of six cases. Mod Pathol. 1993;6:526–30.
Kalluri R, Meyers K, Mogyorosi A, Madaio MP, Nielson EG. Goodpasture syndrome involving overlap with Wegener’s granulomatosis and anti-glomerular basement membrane disease. J Am Soc Nephrol. 1997;8:1795–800.
Peces R, Rodriguez M, Pobes A, Seco M. Sequential development of pulmonary hemorrhage with MPO-ANCA complicating anti-glomerular basement membrane antibody mediated glomerulonephritis. Am J Kidney Dis. 2000;35:954–7.
Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, et al. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCA in crescentic glomerulonephritis. Am J Kidney Dis. 2005;46:253–62.
Yang G, Tang Z, Chen Y, Zeng C, Chen H, Liu Z, et al. Antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with anti-GBM crescentic glomerulonephritis. Clin Nephrol. 2005;63:426–8.
Nakabayashi K, Fujioka Y, Nagasawa T, Kimura K, Kojima K, Arimura Y, et al. Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases. Clin Exp Nephrol. 2011. doi:https://doi.org/10.1007/s10157-010-0390-0.
Hellmark T, Niles JL, Collins AB, McCluskey RT, Brunmark C. Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol. 1997;8:376–85.
Segelmark M, Hellmark T, Wieslander J. The prognostic significance in Goodpasture’s disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies. Nephron Clin Pract. 2003;94:C59–68.
Nakabayashi K, Sumiishi A, Sano K, Fujioka Y, Yamada A, Karube M, et al. Tubulointerstitial nephritis without glomerular lesions in three patients with myeloperoxidase-ANCA-associated vasculitis. Clin Exp Nephrol. 2009;13:605–13.
Jennette JC, Olson JL, Schwartz MM, Silvia FG. Primer on the pathologic diagnosis of renal disease. In: Jennette JC, Olson JN, Schwartz MM, Silvia FG, editors. The Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 97–123.
Teague CA, Doak PB, Simpton IJ, Rainer SP, Hendsen PB. Goodpasture’s syndrome: an analysis of 29 cases. Kidney Int. 1978;13:492–504.
Proskey AJ, Weatherbee L, Eastering RE, Greene JA, Weller JM. Goodpasture’s syndrome. A report of five cases and review of the literature. Am J Med. 1970;48:162–73.
Walker RG, Scheinkestel C, Becker GJ, Owen JE, Dowling JP, Kincaid-Smith P. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture’s syndrome. Q J Med. 1985;54:75–89.
Herody M, Bobrie G, Gouarin C, Grünfeld JP, Noel LH. Anti-GBM disease: predictive value of clinical, histological and serological data. Clin Nephrol. 1993;40:249–55.
Wu M-J, Rajaram R, Shelp WD, Beirne GJ, Burkholder PM. Vasculitis in Goodpasture’s syndrome. Arch Pathol Lab Med. 1980;104:300–2.
Kondo N, Tateno M, Yamaguchi J, Yoshiki T, Itoh T, Kawashima N, et al. Immunopathological studies of an autopsy case with Goodpasture’s syndrome and systemic necrotizing angiitis. Acta Pathol Jpn. 1986;36:595–604.
Jennette JC, Nickeleit V. Anti-glomerular basement membrane glomerulonephritis and Goodpasture’s syndrome. In: Jennette JC, Olson JL, Schwartz MM, Silvia FG, editors. The Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott, Williams & Wilkins; 2007. p. 613–41.
Castleman B, McNeeley BU. Case records of the Massachusetts General Hospital. N Engl J Med. 1971;285:1187–96.
Lewis EJ, Cavallo T, Harrington JT, Cotran RS. An immunopathologic study of rapidly progress glomerulonephritis in the adult. Hum Pathol. 1971;2:185–208.
Wahls TL, Bonsib SM, Schuster LV. Coexistent Wegener’s granulomatosis and anti-glomerular basement membrane disease. Hum Pathol. 1987;18:202–5.
Komadina KH, Houk RW, Vicks SL, Desrosier KF, Ridley DJ, Boswell RN. Goodpasture’s syndrome associated with pulmonary eosinophilic vasculitis. J Rheumatol. 1988;15:1298–301.
Shurbaji MS, Epstein JI. Testicular vasculitis: implications for systemic disease. Hum Pathol. 1988;19:186–9.
Serratrice J, Chiche, Dussol B, Granel B, Daniel l, Jego-Despalt, et al. Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis 2004;43:E14–30.
Acknowledgments
This work was supported in part by grants (2001–2007) from the Research Committee of Refractory Vasculitis Syndrome sponsored by the Ministry of Health, Labor, and Welfare of Japan. We thank Dr. Hiroaki Sugisaki, Director of Fuchuu Dialysis Clinic, for providing the clinical data on the patients. We also thank Mss. Katuko Sano and Ayumi Sumiishi for their excellent technical assistance on the immunohistochemical staining.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Nakabayashi, K., Fujioka, Y., Arimura, Y. et al. Anti-glomerular basement membrane (anti-GBM) disease accompanied by vasculitis that was not positive for antineutrophil cytoplasmic antibodies to myeloperoxidase and proteinase 3: a report of two cases and the incidence of anti-GBM disease at one institution. Clin Exp Nephrol 15, 504–513 (2011). https://doi.org/10.1007/s10157-011-0435-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-011-0435-z